Indications and uses
to soothe: • itching • flea bites • dermatitis • skin irritations • eczema
to soothe: • itching • flea bites • dermatitis • skin irritations • eczema
• rinse pet with warm water until coat is thoroughly wet • massage shampoo thoroughly into the coat • continue massaging and add water during the process to make sure the shampoo is thoroughly distributed through the coat • leave the pet in lather for 5-10 minutes keeping the pet warm and out of drafts • rinse thoroughly and dry • for best results use at least twice a week or as directed by a veterinarian • Indivi...
Hydrocortisone Acetate 0.50%
Anti-itch
to soothe: • itching • flea bites • dermatitis • skin irritations • eczema
For external use only. Use for all adult dogs.
and animals to avoid unintended consumption.
• in eyes or nose •where infection (pus) is present, since the drug may allow infection to be spread •on pregnant animals.
• if product appears to be tampered with. Not for prolonged use.
if redness, irritation, or swelling persists or increases.
• rinse pet with warm water until coat is thoroughly wet
• massage shampoo thoroughly into the coat
• continue massaging and add water during the process to make sure the shampoo is thoroughly distributed through the coat
• leave the pet in lather for 5-10 minutes keeping the pet warm and out of drafts
• rinse thoroughly and dry
• for best results use at least twice a week or as directed by a veterinarian
• Individual result may vary
Store product in cool. dry place. Avoid temperatures above 86F.
Deionized Water, Sodium Lauryl Ether Sulfate, Acrylates Copolymer, Cocamidopropyl Betaine. Cocamidopropylamine Oxide, PEG-3 Distearate,
Aloe Barbadensis Leal Juice, Lauryl Glucoside, Triethanolamine. Lactic Acid, DMDM Hydantoin, Methylparaben, Propylparaben, Fragrance.
(800) 530-2178
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| HYDROCORTISONE ACETATE | ACTIVE INGREDIENT | 3X7931PO74 | 4 | |
| HYDROCORTISONE | ACTIVE MOIETY | WI4X0X7BPJ | 4 | |
| ALOE VERA LEAF | INACTIVE INGREDIENT | ZY81Z83H0X | 4 | |
| COCAMIDOPROPYL BETAINE | INACTIVE INGREDIENT | 5OCF3O11KX | 4 | |
| COCAMIDOPROPYLAMINE OXIDE | INACTIVE INGREDIENT | M4SL82J7HK | 4 | |
| COCO DIETHANOLAMIDE | INACTIVE INGREDIENT | 92005F972D | 4 | |
| DMDM HYDANTOIN | INACTIVE INGREDIENT | BYR0546TOW | 4 | |
| LACTIC ACID | INACTIVE INGREDIENT | 33X04XA5AT | 4 | |
| METHACRYLATE/METHOXY PEG-10 MALEATE/STYRENE COPOLYMER | INACTIVE INGREDIENT | 39DK5WQ2PR | 4 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | 4 | |
| PEG-3 DISTEARATE | INACTIVE INGREDIENT | 8420ECX438 | 4 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | 4 | |
| SODIUM LAURETH-2 SULFATE | INACTIVE INGREDIENT | ZZQ59TY3KG | 4 | |
| TROLAMINE | INACTIVE INGREDIENT | 9O3K93S3TK | 4 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 4 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 60754-920 | 60754-920-08 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | ENEMA / RECTAL | 0.18 %w/v | ||
| LACTIC ACID | LACTIC ACID | 33X04XA5AT | INJECTION, SOLUTION / INTRAVENOUS | 87 mg | ||
| COCO DIETHANOLAMIDE | COCO DIETHANOLAMIDE | 92005F972D | SOLUTION / TOPICAL | 2.5 %w/v | ||
| LACTIC ACID | LACTIC ACID | 33X04XA5AT | SUSPENSION / TOPICAL | 0.7 %w/w | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 0.4 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | DROPS / NASAL | 14 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | OINTMENT / TOPICAL | 0.2 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SHAMPOO / TOPICAL | 0.15 %w/w | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | DROPS / OPHTHALMIC | 0.01 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | AEROSOL, FOAM / TOPICAL | 0.16 %w/w | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION, CONCENTRATE / ORAL | 0.2 mg/1ml | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / IONTOPHORESIS | 0.1 %w/v | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | SOLUTION / TOPICAL | NA | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | CREAM / VAGINAL | 56 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | TABLET, CHEWABLE / ORAL | 1.28 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION, EXTENDED RELEASE / ORAL | 40 mg | ||
| LACTIC ACID | LACTIC ACID | 33X04XA5AT | GEL / TOPICAL | 30 mg | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | LIQUID / TOPICAL | NA | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / PARENTERAL | 18 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / IRRIGATION | 2 %w/v | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | TABLET, CHEWABLE / ORAL | 0.14 mg | ||
| COCO DIETHANOLAMIDE | COCO DIETHANOLAMIDE | 92005F972D | CREAM / TOPICAL | 30 mg | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | AEROSOL, FOAM / TOPICAL | 2.6 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | OINTMENT / OPHTHALMIC | 0.05 %w/w | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | AEROSOL, METERED / RECTAL | ADJ PH | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | LOTION / TOPICAL | 140 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | CREAM / VAGINAL | 22 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION, SOLUTION / INTRAVENOUS | 5 mg | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | GEL, METERED / TRANSDERMAL | 14 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | CAPSULE, EXTENDED RELEASE / ORAL | 2 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / INTRAVENOUS | 0.02 %w/v | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | POWDER / ORAL | NA | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | LOTION / TOPICAL | 360 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / INTRADERMAL | 1 mg | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | CREAM, AUGMENTED / TOPICAL | 20 mg | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | EMULSION / TOPICAL | 0.5 %w/w | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / ORAL | 100 mg | ||
| LACTIC ACID | LACTIC ACID | 33X04XA5AT | AEROSOL, FOAM / TOPICAL | 11 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION/ DROPS / OPHTHALMIC | 0.05 %w/v | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | POWDER, FOR SUSPENSION / ORAL | 8 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 0.8 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / INTRAMUSCULAR | 0.02 %w/v | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | CAPSULE, EXTENDED RELEASE / ORAL | 0.22 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | CREAM, AUGMENTED / TOPICAL | 2 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / OPHTHALMIC | 0.02 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / PERINEURAL | 80 mg | ||
| COCO DIETHANOLAMIDE | COCO DIETHANOLAMIDE | 92005F972D | SHAMPOO / TOPICAL | 600 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION / ORAL | 388 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | CREAM / TOPICAL | 3000 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | JELLY / TOPICAL | 180 mg | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | SHAMPOO / TOPICAL | 3.7 %w/w | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SHAMPOO / TOPICAL | 0.03 %w/w | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SUSPENSION / SUBCUTANEOUS | 0.02 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 15 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION / SUBCUTANEOUS | 0.16 %w/v | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | TABLET, COATED / ORAL | 0.8 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | AEROSOL, FOAM / VAGINAL | 0.1 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUPPOSITORY / VAGINAL | NA | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / PARENTERAL | 30 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / RECTAL | 0.13 %w/v |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydrocortisone | HYDROCORTISONE | American Health Packaging | 506aab0d-9308-4d60-90b3-7d64952fff36 | 2026-08-31 | Warnings, Adverse reactions | Hydrocortisone |
| Hydrocortisone Acetate | HYDROCORTISONE ACETATE | Preferred Pharmaceuticals, Inc. | 247bb729-f0b6-4325-a9f8-4b46d5cda300 | 2026-08-28 | Adverse reactions | HYDROCORTISONE ACETATE |
| Hydrocortisone | HYDROCORTISONE | Amazon.com Services LLC | 5f87d7fb-f258-48b0-8b60-1055e22ebd71 | 2026-08-25 | Warnings | Hydrocortisone |
| Claravie | HYDROCORTISONE ACETATE | Gentell LLC | 598d224b-d12e-89bf-e063-6394a90a84dc | 2026-08-21 | Warnings | HYDROCORTISONE ACETATE |
| Hydrocortisone | HYDROCORTISONE | Safetec of America, Inc. | da2b3b2c-11e0-401b-bbd2-d019271d1b3d | 2026-08-13 | Warnings | Hydrocortisone |
| HYDROCORTISONE | HYDROCORTISONE | Amazon.com Services LLC | f40b4223-e81f-4cd0-bc9b-d3d33ce8cce5 | 2026-08-12 | Warnings | HYDROCORTISONE |
| Hydrocortisone | HYDROCORTISONE | Solco Healthcare LLC | 04f112e5-ec88-46c8-b675-8b4e38a86ab4 | 2026-08-11 | Warnings, Adverse reactions | Hydrocortisone |
| hydrocortisone | HYDROCORTISONE | Bryant Ranch Prepack | 484fe5e4-a058-49c0-a382-c8fc3e20c3b2 | 2026-08-04 | Warnings | hydrocortisone |
| procure | HYDROCORTISONE ACETATE | TWIN MED, LLC | 2670c9c4-66ad-40e8-a08a-582b160de39d | 2026-08-03 | Warnings | HYDROCORTISONE ACETATE |
| Hydrocortisone | HYDROCORTISONE | REMEDYREPACK INC. | f0e66726-946b-4f63-b457-2851dc69e6b4 | 2026-08-03 | Adverse reactions | Hydrocortisone |
| hydrocortisone | HYDROCORTISONE | Eywa Pharma Inc | b3f06d10-2f01-428c-88a4-505c61c87ce8 | 2026-07-25 | Warnings, Adverse reactions | hydrocortisone |
| Hydrocortisone | HYDROCORTISONE | AKRON PHARMA INC | daad9a1e-98d2-4ce7-9d97-ac5d81905abb | 2026-07-22 | Warnings | Hydrocortisone |
| Hydrocortisone | HYDROCORTISONE LOTION | Allegis Holdings LLC | 1a27d8fa-4025-ed68-e063-6394a90a4f37 | 2026-07-08 | Warnings, Adverse reactions | Hydrocortisone |
| Hydrocortisone | HYDROCORTISONE | Encube Ethicals, Inc. | 11e120e2-a1ca-477c-b474-bcbb72656705 | 2026-06-26 | Adverse reactions | Hydrocortisone |
| Hydrocortisone | HYDROCORTISONE | Mylan Pharmaceuticals Inc. | bc751403-94f2-4f9d-b533-cf6186a40ceb | 2026-05-25 | Warnings, Adverse reactions | Hydrocortisone |
| Hydrocortisone | HYDROCORTISONE | Bryant Ranch Prepack | 04758c46-0ca4-4852-acdc-1f8553ce2e6e | 2026-05-21 | Adverse reactions | Hydrocortisone |
| Hydrocortisone | HYDROCORTISONE | Preferred Pharmaceuticals Inc. | 02ab1006-c7c8-42c9-bda8-62c9d7142521 | 2026-05-11 | Adverse reactions | Hydrocortisone |
| Hydrocortisone | HYDROCORTISONE | Preferred Pharmaceuticals, Inc. | 058bb2ff-ff51-4a3b-ba47-cb02272d0631 | 2026-05-11 | Adverse reactions | Hydrocortisone |
| hydrocortisone | HYDROCORTISONE | Preferred Pharmaceuticals Inc. | 12cd35e3-e707-4551-b778-bf615c1a8d32 | 2026-05-11 | Warnings | hydrocortisone |
| HYDROCORTISONE | HYDROCORTISONE | Preferred Pharmaceuticals Inc. | 0bbb8a63-ae1d-41d7-b201-d1b171b31f46 | 2026-05-11 | Warnings, Adverse reactions | HYDROCORTISONE |
Adverse event summaries are temporarily unavailable. Other product information remains available.